Prediction of psychiatric comorbidity on premature death in a cohort of patients with substance use disorders: a 42-year follow-up

被引:39
|
作者
Fridell, Mats [1 ]
Backstrom, Martin [1 ]
Hesse, Morten [2 ]
Krantz, Peter [3 ]
Perrin, Sean [1 ]
Nyhlen, Anna [4 ]
机构
[1] Lund Univ, Dept Psychol, SE-22100 Lund, Sweden
[2] Univ Aarhus, Ctr Alcohol & Drug Res, Bartholins Alle, DK-8000 Aarhus C, Denmark
[3] Lund Univ Hosp, Dept Forens Med, SE-22185 Lund, Sweden
[4] Malmo Univ Hosp, Dept Psychiat, SE-20502 Malmo, Sweden
关键词
Cohort study; Premature death; 42-year follow-up; Drug abuse; Psychiatric comorbidity; Personality disorder; Somatic comorbidity; NATIONAL EPIDEMIOLOGIC SURVEY; PERSONALITY-DISORDERS; OVERDOSE MORTALITY; SCID-II; CANNABIS; AMPHETAMINE; PSYCHOSIS; ALCOHOL; PEOPLE; COOCCURRENCE;
D O I
10.1186/s12888-019-2098-3
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
BackgroundWe need to better understand how the use of different substances and psychiatric comorbidity influence premature death generally and cause-specific death by overdose, intoxication and somatic disorders in people with substance use disorders.MethodA cohort of 1405 patients consecutively admitted to a Swedish detoxification unit for substance use disorders in 1970-1995 was followed-up for 42years. Substances were identified by toxicological analyses. Mortality figures were obtained from a national registry. Causes of death were diagnosed by forensic autopsy in 594 patients deceased by 2012. Predictions were calculated by competing risks analysis.ResultsForty-two per cent of the cohort died during follow-up; more men than women (46.3% vs 30.4%). The standardised mortality ratio (SMR) was calculated as the ratio of observed deaths in males and females in specific age groups in the cohort versus expected deaths in corresponding groups in the general population. SMR was 5.68 for men (CI 95%; 5.04-6.11) and 4.98 (CI 95%; 4.08-5.88) for women. The crude mortality rate (number of deaths divided by number of person observation years) was 2.28% for men and 1.87% for women.Opiates predicted increased risk of premature death while amphetamine and cannabis predicted lower risk. Comorbid psychiatric disorders were identified in 378 cases and personality disorders in 763 cases. Primary psychoses or mood/depression and anxiety disorders predicted a higher risk of premature mortality.Death by overdose was predicted by male gender, younger age at admission to substance treatment, opiate use, and comorbid depression and anxiety syndromes. Cannabis and amphetamine use predicted a lower risk of overdose. Death by intoxication was predicted by male gender, use of sedatives/hypnotics or alcohol/mixed substances, primary psychoses and depression/anxiety syndromes. Premature death by somatic disorder was predicted by male gender and alcohol/mixed abuse.ConclusionPsychiatric comorbid disorders were important risk factors for premature drug-related death. Early identification of these factors may be life-saving in the treatment of patients with substance use disorders.
引用
下载
收藏
页数:13
相关论文
共 50 条
  • [21] Effects of stimulant treatment on subsequent substance use disorders and other psychiatric disorders in ADHD youth grown up: a prospective 10 year follow-up study
    Biederman, J.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2009, 19 : S209 - S209
  • [22] Criminal activities and substance use of patients with major affective disorders and schizophrenia: a 2-year follow-up
    Hodgins, S
    Lapalme, M
    Toupin, J
    JOURNAL OF AFFECTIVE DISORDERS, 1999, 55 (2-3) : 187 - 202
  • [23] Psychiatric disorders in burn patients: A follow-up study
    Madianos, MG
    Papaghelis, M
    Ioannovich, J
    Dafni, R
    PSYCHOTHERAPY AND PSYCHOSOMATICS, 2001, 70 (01) : 30 - 37
  • [24] Psychiatric comorbidity in ecstasy users: A one year follow-up controlled study
    Gines, JM
    Fonseca, F
    Poudevida, S
    Farre, M
    De la Torre, R
    Martin-Santos, R
    Torrens, M
    EUROPEAN PSYCHIATRY, 2004, 19 : 158S - 159S
  • [25] Premature death associated with delirium at 1-year follow-up
    Leslie, DL
    Zhang, Y
    Holford, TR
    Bogardus, ST
    Leo-Summers, LS
    Inouye, SK
    ARCHIVES OF INTERNAL MEDICINE, 2005, 165 (14) : 1657 - 1662
  • [26] Psychiatric comorbidity in patients with substance use disorders: Do not forget Axis II disorders
    Cacciola, JS
    Alterman, AI
    McKay, JR
    Rutherford, MJ
    PSYCHIATRIC ANNALS, 2001, 31 (05) : 321 - 331
  • [27] A 12 YEAR PSYCHIATRIC FOLLOW-UP OF GASTRECTOMY PATIENTS
    BROWN, GL
    WILSON, WP
    POSTLETHWAIT, RW
    PARKER, JB
    SOUTHERN MEDICAL JOURNAL, 1970, 63 (09) : 1005 - +
  • [28] Substance abuse relapse in a ten-year prospective follow-up of clients with mental and substance use disorders
    Xie, HY
    McHugo, GJ
    Fox, MB
    Drake, RE
    PSYCHIATRIC SERVICES, 2005, 56 (10) : 1282 - 1287
  • [29] Twelve-month prospective follow-up of patients with schizophrenia-spectrum disorders and substance abuse: Changes in psychiatric symptoms and substance use
    Margolese, HC
    Negrete, JC
    Tempier, R
    Gill, K
    SCHIZOPHRENIA BULLETIN, 2005, 31 (02) : 206 - 206
  • [30] Mental disorders as risk factors for substance use, abuse and dependence: results from the 10-year follow-up of the National Comorbidity Survey
    Swendsen, Joel
    Conway, Kevin P.
    Degenhardt, Louisa
    Glantz, Meyer
    Jin, Robert
    Merikangas, Kathleen R.
    Sampson, Nancy
    Kessler, Ronald C.
    ADDICTION, 2010, 105 (06) : 1117 - 1128